✦ LIBER ✦

Advances in the understanding and management of myeloproliferative disorders

✍ Scribed by Radek Skoda

Book ID: 114794265
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 58 KB
Volume: 79
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2007.00934.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advances in Understanding and Management

Advances in Understanding and Management of Myeloproliferative Neoplasms

✍ Alessandro M. Vannucchi; Paola Guglielmelli; Ayalew Tefferi 📂 Article 📅 2009 🏛 American Cancer Society 🌐 English ⚖ 324 KB

Treatment paradigms in the management of

Treatment paradigms in the management of myeloproliferative disorders

✍ Steven M Fruchtman 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Recent Advances in the Understanding and

Recent Advances in the Understanding and Treatment of Anxiety Disorders

✍ Shearer, Steven L. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 254 KB

Advances in the management of histiocyti

Advances in the management of histiocytic disorders

✍ Kevin Windebank 📂 Article 📅 2008 🏛 Medicine Publishing Company Ltd 🌐 English ⚖ 868 KB

Advances in the understanding and manage

Advances in the understanding and management of autoimmune enteropathy

✍ Simon Murch 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 410 KB

New perspectives in managing myeloprolif

New perspectives in managing myeloproliferative disorders: focus on the patient

✍ Gunnar Birgegård 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

## Abstract Risk stratification is the basis for treatment decisions in the chronic myeloproliferative disorders, and in addition to the three established risk factors of previous thrombosis, age and platelets >1500 × 10^9^, cardiovascular risk factors should be addressed. In addition, premorbidity